Circadia Health

The company develops the FDA-cleared Circadia C200 System, a contactless monitoring platform that tracks respiration, heart rate, bed exits, and motion for patients in post-acute care settings including skilled-nursing, home-health, and home-care networks. Their technology currently monitors 40,000+ patients daily and records approximately 115 million respiratory rate values daily. The company is venture-backed and employs approximately 120 people. For nursing professionals, Circadia offers a non-traditional role: on-site Nurse Practitioners who visit post-acute care facilities, act on predictive health signals in real time, and coach facility teams to translate data into earlier clinical interventions. The NP role focuses on reducing preventable readmissions by leveraging AI-driven early detection rather than conventional bedside nursing. This is a technology-company environment where nurses work at the intersection of clinical practice and AI innovation, operating across multiple facility sites rather than within a single hospital or clinic. The listed location of Bangor, ME likely represents a field-based assignment territory rather than a corporate office.

Circadia Health's mission is to build tools that reduce the risks and costs of preventable readmissions due to respiratory complications, heart failure, and infections. They aim to democratize tools that improve clinical decision-making and make predictive care possible, shifting healthcare from a reactionary model to a proactive one. Their stated goal is to reduce rehospitalizations by helping providers detect changes in patient health before they worsen, ultimately saving lives across the post-acute care continuum.